
© 2024 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
389,90 | 391,50 | 09.06. | |
389,35 | 391,75 | 09.06. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? | ||
Fr | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference | - Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with... ► Artikel lesen | |
28.05. | Lilly takes on Vertex in non-opioid pain with SiteOne buy | ||
28.05. | 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow | ||
27.05. | Eli Lilly Commits $1B to Get Drug That Could Rival Vertex's New Non-Opioid Pain Med |